Development of a Preclinical Model for Hormonal Therapy of Human Endometrial Carcinomas

References

• Silverberg E, Boring C C, Squares B A. Cancer statistics 1990. CA 1990; 90: 40
   Google Scholar
• ACOG Technical Bulletin. Carcinoma of the endometrium. December, 1991; 1–6, No. 162
   Google Scholar
• Kelley P M, Baker W H. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 1960; 264: 216–22
   Google Scholar
• Deppe G. Chemotherapy of endometrial carcinoma. Chemotherapy of gynecologic cancer, G Deppe. Alan R. Liss, Inc., New York 1984; 139–50
   Google Scholar
• Jensen E U, DeSombre E R. Mechanism of action of female sex hormones. Annu Rev Biochem 1972; 41: 203–30
   PubMed Web of Science ®Google Scholar
• Gorski J, Ganong F. Current models of steroid hormone action: a critique. Annu Rev Physiol 1976; 38: 425–50
   PubMed Web of Science ®Google Scholar
• McGuire W L, Carbone P O, Vollmer E P. Estrogen receptors in human breast cancer. Raven Press, New York 1975; 1
   Google Scholar
• Allegra J C, Lippman M E, Thompson E B, et al. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Treat Rep 1978; 62: 1281–6
   PubMedGoogle Scholar
• McGuire W L. Hormones, receptors and breast cancer. Raven Press, New York 1978; 11
   Google Scholar
• Mortel R, Zaino R J, Satyaswaroop P G. Sex steroid receptors and hormonal treatment of endometrial cancer. Chemotherapy of gynecologic cancer, G Deppe. Alan R. Liss, Inc., New York 1984; 125–38
   Google Scholar
• Martin P M, Rolland P H, Gammere M, Serment H, Toga M. Estradiol and progesterone receptors in normal and neoplastic endometrial: correlations between receptors, histo-pathological examinations and clinical responses under progestin therapy. Int J. Cancer 1979; 24: 324–9
   Google Scholar
• Benraad T J, Friberg L G, Koenders A J M, Kullander S. Do estrogen and progesterone receptors in metastasizing endometrial cancers predict the response to gestagen therapy?. Acta Obstet Gynecol Scand 1980; 59: 155–9
   PubMed Web of Science ®Google Scholar
• Creasman W T, McCarty K S, Sr, Barton T K, McCarty K S, Sr. Clinical correlates of estrogen and progesterone binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 1980; 55: 363–70
   PubMedGoogle Scholar
• Kaupplla A, Kujansuu E, Vihko R. Cytosol estrogen and progesterone receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlates. Cancer 1982; 50: 2157–61
   PubMedGoogle Scholar
• Martin P M. Endometrial cancer: correlations between estrogen and progestin receptor status, histopathological findings, and clinical responses during progestin therapy. Excerpta Med Int Can Series 1982; 611: 333–49
   Google Scholar
• Mortel R, Levy C, Wolff J-P, Nicholas J-C, Robel P, Baulieu E-E. Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to antiestrogen. Cancer Res 1981; 41: 140–7
   Google Scholar
• Hormonal biology of endometrial cancer, G S Richardson, D T MacLaughlin. International Union Against Cancer, Geneva 1978; Vol. 42, UICC Technical Report Series
   Google Scholar
• Hughes E C, Demers L M, Csormely T, Jones D B. Organ culture of human endometrium. Am J Obstet Gynecol 1969; 105: 707–20
   PubMedGoogle Scholar
• Shapiro S S, Dyer R D, Colas A E. Progesterone-induced glycogen accumulation in human endometrium during organ culture. Am J Obstet Gynecol 1980; 136: 419–25
   PubMedGoogle Scholar
• Tseng L, Gurpide E. Stimulation of various 17β- and 20α-hydroxysteroid dehydrogenase activities by progestins in human endometrium. Endocrinology 1979; 104: 1745–8
   PubMedGoogle Scholar
• Satyaswaroop P G, Wartell D J, Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase and 20α-dihydro-progesterone dehydrogenase activities in human endometrial glands and stroma; progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium. Endocrinology 1982; 111: 743–9
   PubMedGoogle Scholar
• Satyaswaroop P G, Mortel R. Failure of progestins to induce estradiol dehydrogenase activirty in endometrial carcinoma, in vitro. Cancer Res 1982; 42: 1322–5
   PubMedGoogle Scholar
• Kuramoto H, Tamura S, Notake Y. Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol 1972; 114: 1012–19
   PubMed Web of Science ®Google Scholar
• Merenda C, Sordat B, Mach J P, Carrel S. Human endometrial carcinomas serially transplanted in nude mice and established in continuous cell line. Int J Cancer 1975; 16: 559–70
   PubMedGoogle Scholar
• Ishiwata I, Nozawa S, Inoue T, Okumura H. Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma. Cancer Res 1977; 37: 1777–85
   PubMed Web of Science ®Google Scholar
• Gorodeckl J, Mortel R, Ward S P, Geder L, Rapp F. Establishment and characterization of a new endometrial cancer cell line (SCRC-1). Am J Obstet Gynecol 1979; 135: 671–9
   PubMedGoogle Scholar
• Way D L, Grosso D S, Davis J R, Surwit E A, Christian C D. Characterization of a new human endometrial carcinoma (RL 95.2) established in tissue culture. In Vitro 1983; 19: 147–58
   PubMedGoogle Scholar
• Richardson G S, Dlckersin G R, Atkins L, MacLaughlin D T, Raaom S, Merk L P, Bradley F M. KLE: A cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol 1984; 17: 213–30
   PubMedGoogle Scholar
• Nishida M, Kasahara K, Kaneko M, Wasaki H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynaecol Japonica 1985; 37: 1103–11
   Google Scholar
• Satyaswaroop P G, Sivarajah A, Zaino R J, Mortel R. Hormonal control of growth of human endometrial carcinoma in the nude mouse model. Prog Cancer Res Ther, F Bresciani, R G B King, M E Lippman. Raven Press, New York 1988; 430–5
   Google Scholar
• Mortel R, Zaino R J, Satyaswaroop P G. Heterogeneity and progesterone receptor distribution in endometrial adenocarcinoma. Cancer 1984; 53: 113–6
   PubMedGoogle Scholar
• Satyaswaroop P G, Zaino R, Mortel R. Human endometrial adenocarcinoma transplanted into nude mice: growth regulation by estradiol. Science 1983; 219: 58–60
   PubMedGoogle Scholar
• Satyaswaroop P G, Zaino R J, Mortel R. Steroid receptors and human endometrial carcinoma: Studies in a nude mouse model. Cancer Metastasis Rev 1987; 6: 223–41
   PubMedGoogle Scholar
• Clarke C L, Zaino R J, Fell P D, et al. Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 1987; 121: 1123–32
   PubMed Web of Science ®Google Scholar
• Zaino R J, Clarke C L, Mortel R, Satyaswaroop P G. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 1988; 48: 1889–95
   PubMedGoogle Scholar
• Satyaswaroop P G, Zaino R J, Mortel R. Estrogen-like effect of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 1984; 44: 4006–10
   PubMed Web of Science ®Google Scholar
• Zaino R J, Satyaswaroop P G, Mortel R. Morphology of human uterine cancer in nude mice. Arch Pathol Lab Med 1984; 108: 571–8
   PubMedGoogle Scholar
• Zaino R J, Satyaswaroop P G, Mortel R. Hormonal therapy of human endometrial carcinoma in a nude mouse model. Cancer Res 1985; 45: 539–41
   PubMedGoogle Scholar
• Mortel R, Satyaswaroop P G, Clarke C L, Zaino R. Sex steroid receptors in normal and malignant endometrium. Ann Pathol 1986; 6: 109–14
   PubMedGoogle Scholar
• Satyaswaroop P G, Clarke C L, Zaino R J, Mortel R. Apparent resistance of human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. Cancer Lett 1992; 62: 107–14
   PubMedGoogle Scholar
• Mortel R, Zaino R J, Satyaswaroop P G. Designing a schedule of progestin administration in the control of endometrial carcinoma growth in the nude mouse model. Am J Obstet Gynecol 1990; 162: 928–36
   PubMedGoogle Scholar